Effect of chromium administration in controlling blood sugar in diabetic patients
Phase 2
- Conditions
- Diabetes mellitus.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT201009264817N1
- Lead Sponsor
- Research Deputy, Jundishapur University Of Ahvaz
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
type 2 diabetic patients with HbA1C>7%
Exclusion criteria: renal, hepatic, or heart failure
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1C. Timepoint: at first and 3 months later. Method of measurement: HPLC.;FBS. Timepoint: at first and 3 months later. Method of measurement: R-1000 device.
- Secondary Outcome Measures
Name Time Method BMI. Timepoint: At first and 3 month later. Method of measurement: weight/height2.;Serum chromium level. Timepoint: at first and 3 months later. Method of measurement: Atomic absorption spectrophotometry.;Serum lipids. Timepoint: At first and 3 months later. Method of measurement: Direct LDL-Chol.